Reuters logo
Endo to buy DAVA Pharma for $575 million
June 24, 2014 / 1:25 PM / 3 years ago

Endo to buy DAVA Pharma for $575 million

June 24 (Reuters) - Drugmaker Endo International Plc said it would buy privately owned DAVA Pharmaceuticals Inc for $575 million in cash.

The deal, expected to add to Endo’s 2014 adjusted earnings per share, has an additional cash consideration of up to $25 million, on achieving certain sales milestones. (Reporting by Shailesh Kuber; Editing by Don Sebastian)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below